Abstract
The low efficiency during the delivery of nucleic acids to tumor cells is a recurring problem in gene therapy studies for the treatment of cancer. This problem is mainly caused by the difficulty in directing and transporting the therapeutic molecules to the target cells due to the presence of numerous physical, enzymatic and diffusional barriers. Over the past few years, our research grou…